From scientific evidence to clinical experience

Scientific innovation and development of neuromodulation devices

Our devices are in: Andorra | Australia | Austria | Belgium | Bosnia and Herzegovina | Brazil | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech Republic | Dominican Republic | Emirates | France | Georgia | Germany | Gibraltar | Greece | Guatemala | Hong Kong | Hungary | Ireland | Italy | Kuwait | Latvia | Luxembourg | Mexico | Mauritius | Netherlands | Niue Island | Panama | Peru | Poland | Portugal | Qatar | Romania | Russia | Serbia | Slovenia | Sweden | Switzerland | Turkey | United Kingdom | United States | Uruguay | Venezuela | Our devices are in: Andorra | Australia | Austria | Belgium | Bosnia and Herzegovina | Brazil | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech Republic | Dominican Republic | Emirates | France | Georgia | Germany | Gibraltar | Greece | Guatemala | Hong Kong | Hungary | Ireland | Italy | Kuwait | Latvia | Luxembourg | Mexico | Mauritius | Netherlands | Niue Island | Panama | Peru | Poland | Portugal | Qatar | Romania | Russia | Serbia | Slovenia | Sweden | Switzerland | Turkey | United Kingdom | United States | Uruguay | Venezuela

Our techniques

We provide the medical technology necessary to provide health solutions for society, applying neuromodulation in a comprehensive and transversal manner at the level of the central and peripheral nervous system.

Why Ionclinics

Accredited devices

All EU-approved indications in a single tDCS device

Evidence-based protocol

Application with +30,000 studies in our techniques.

Continuous development

R&D department and up-to-date training in clinical application.

Who trust us

Courses

Since 2015, at Ionclinics we have been committed to offering quality training for healthcare professionals who want to boost their careers and offer better treatments to their patients.

Opinions from professionals

"We have implemented the tDCS treatment and the results are well above expectations. We work in collaboration with the psychiatry and psychology departments and it is a very interesting complement to improve the quality of life of our patients".

"Of course, tDCS in the chronic patient is one of the few effective tools we have that creates a change that we can see.



We have to focus on making it as functional as possible".

Do you have questions? We are here to help you.

Lanzamiento Home tDCS

Lanzamiento Home tDCS

El único dispositivo con opción hospitalaria y domiciliaria certificado bajo MDR, sin necesidad de supervisión por parte del profesional sanitario.

El único dispositivo con opción hospitalaria y domiciliaria certificado bajo MDR, sin necesidad de supervisión por parte del profesional sanitario.